We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is an Isograft?

Mary McMahon
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

An isograft is a transplant with donor material from someone who is genetically identical to the recipient. The primary advantage to this type of transplant is that the risk of rejection is minimal because the donor and host share a major histocompatibility complex. In rare instances, a condition called graft versus host disease can develop, but this is extremely unusual, especially when compared with allografts from members of the same species. Such grafts come from hosts who are carefully screened as matches, but are genetically different.

Some examples of procedures that can involve an isograft may include bone marrow transplant and kidney transplant from living donors, along with donations of cadaver tissue. Monozygotic twins can donate tissue and organs to each other for use in isografts, as long as they pass other tests used to evaluate prospective donors. These can include screens for communicable diseases that might endanger the recipient.

Risks associated with an isograft are generally lower because the body shouldn’t reject the transplant material. It recognizes it as genetically identical and will integrate it like the patient’s own tissue. There are still potential risks of infection and complications around the surgical site, however. Resolving concerns about rejection can make it much more likely that a transplant will be a success, and the patient won’t need aggressive immunosuppressive drugs to force the body to accept the donor tissue.

In some cases, patients develop a triad of symptoms at least three months after an isograft procedure, indicating that they have graft versus host disease. These symptoms include jaundice, rashes, and gastrointestinal distress. Bone marrow or stem cells from the donor in this situation start to attack the recipient’s body, even though it is genetically identical, and this can make the recipient very ill.

When a patient has a medical condition that may require a graft for treatment, such as a bone marrow cancer, the first choice for donor material is a twin, if one is available. If an isograft is not an option, a family member can be a good choice because of the decreased risk of a potential rejection. In situations where a family member is not available or not compatible, patients can be put on a waiting list for donor tissue, or may make private arrangements for donation; for example, people who need kidneys and have willing donors who aren’t matches might perform a kidney swap with other people in the same situation.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a The Health Board researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.